Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:30:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    0.6%
    Check dated 2026-10-25T01:28:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:13:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:41:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the history, and the prior revision v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-20T00:33:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the study history, replacing the previous v3.6.5. This reflects a small update to the page's metadata in the record history.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:37.000Z thumbnail image

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.